21st Century Cures Act - Beau Biden Cancer Moonshot

 

To provide support for initiatives funded under the 21st Century Cures Act to support cancer research, such as the development of cancer vaccines, the development of more sensitive diagnostic tests for cancer, immunotherapy and the development of combination therapies, and research that has the potential to transform the scientific field, that has inherently higher risk, and that seeks to address major challenges related to cancer.

Active 93.353 National Institutes of Health, Department of Health and Human Services B - Project Grants Fiscal Year 2017 FY2017 actual total awards to be made is 48.
Fiscal Year 2018 FY2018 actual total awards to be made is 28.
Fiscal Year 2019 FY2019 actual total awards made is 18.
Fiscal Year 2020 FY2020 actual awards made was 21.
Fiscal Year 2021 FY2021 total awards made was 9.
Fiscal Year 2022 FY2022 actual awards made were 16.
Fiscal Year 2023 FY2023 estimated total awards to be made is 125.
Fiscal Year 2024 FY2024 estimated total awards to be made is 0. Act: Public Health Service Act, Sections 301, 410 and 412, Public Law 78-410, as amended, Public Law 99-500, Public Law 100-607, 42 U.S.C. 241, 42 U.S.C. 285 - 285a-1; Small Business Research and Development Enhancement Act of 1992, Public Law 102-564. The awardee will be a university, college, hospital, public agency, nonprofit research institution or for-profit organization that applies and receives a grant for support of research by a named principal investigator. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council. Any nonprofit or for-profit organization, company, or institution engaged in biomedical research. Applications must be submitted in compliance with instructions provided with each initiative. Preapplication coordination is not applicable. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Grants and cooperative agreements are funded based on scientific merit, program relevance, and program balance and are made annually. The initial grant award provides funds for the first budget period (usually 12 months) and letter Notice of Award indicates support recommended for the remainder of the project period, allocation of Federal funds by budget categories and special conditions, if any. Not applicable. Regular Grants: Approximately 10 months From 15 to 30 days. A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH home page www.nih.gov/grants/guide/notice-files/not97-232.html . From 30 to 60 days. Applications submitted for renewal are reviewed and selected for funding on a competitive basis. Funding decisions are based on scientific merit (42 CFR 52h) and program relevance. Scientific merit review encompasses: the peer review criteria detailed in the specific funding announcement, as well as the significance, approach, and innovation of the proposed research; the competency of the principal investigator; the adequacy of the resources and environment; the proposed budget and requested period of support; and, where applicable, the adequacy of the measures for protecting against adverse effects upon humans, animals, or the environment. Grants and cooperative agreements may be made to eligible institutions for the support of cancer research projects. The grants and cooperative agreements may be used for personnel, consultant costs, equipment, supplies, travel, patient costs, animals, alterations and renovations, miscellaneous items, and Facilities and Administrative Costs (formerly known as indirect costs). Not applicable. Expenditures and other financial records, and also administrative records, must be retained for 3 years from the day on which the grantee submits the last expenditure report for the grant period. Expenditures and other financial records, and also administrative records, must be retained for 3 years from the day on which the grantee submits the last expenditure report for the grant period. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Grants and Cooperative Agreements: Average 3 to 5 years, and a maximum of 5 years. Renewals may be awarded for additional periods of up to 5 years based on competitive peer review. Method of awarding/releasing assistance: Letter. Not applicable Catherine M. Battistone
9609 Medical Center Drive, Suite 7W532
Rockville, MD 20850 US
battistc@mail.nih.gov
Phone: 240-276-6443
Fax: 240-276-7682 https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative 75-0849-0-1-550 (Cooperative Agreements) FY 22$49,889,327.00; FY 23 est $78,925,810.00; FY 24 est $0.00; FY 21$66,987,994.00; FY 20$59,946,333.00; FY 19$96,238,319.00; FY 18$86,243,000.00; FY 17$58,437,000.00; - Range: $315,874 to $4,012,287 Average $1,153,339 45 CFR 75, NIH Grants Policy Statement, SF 424 Not applicable.